ELDN: Eledon Pharmaceuticals Company Short-Term Debt
The transplant immunology biotech sector is currently undergoing clinical trials where growth is constrained by FDA regulations. The market valuation of Eledon Pharmaceuticals (ELDN) serves as a control tool for this niche, with the indicator standing at 0.00. Eledon Pharmaceuticals develops methods to protect transplanted organs. Their approach is based on the use of molecules that block immune failure without hazardous toxins, significantly increasing patients' chances of longevity.
Metric breakdowns and analytics for Eledon Pharmaceuticals, Inc (ELDN)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Eledon Pharmaceuticals|ELDN - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Eledon Pharmaceuticals|ELDN - Company Total Debt|Debt to Book Capitalization Ratio Eledon Pharmaceuticals, Inc.|ELDN - Company Long-Term Liabilities|Company Current Liabilities Eledon Pharmaceuticals|Quick Liquidity eledon.com
- net income and valuation multiples indicators:
Initial company analysis:ELDN - Eledon Pharmaceuticals, Inc.
The indicator is calculated by aggregating all current liabilities with maturities of up to twelve months based on reporting data. This metric measures short-term debt load, which is critical during operational cash flow deficits. For Eledon Pharmaceuticals (ELDN), such costs are rising due to geopolitical risks in reagent supply chains. The current value of 0.00 reflects the financial pressure on the company. Analyzing credit obligations under one year allows for an assessment of liquidity loss risk.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|Upstream Bio Corp - Company Short-Term Debts|Short-Term Debt Zenas Corp|Immunome, Inc. (IMNM) - Company Short-Term Debt|GOSS (gossamerbio.com) - Company Short-Term Debt|KALV (KalVista Pharmaceuticals, Inc.) - Company Short-Term Debts|Short-Term Debt Septerna, Inc. SEPN|Company Short-Term Debts PVLA|Savara Pharma - Company Short-Term Indebtedness|Company Short-Term Debt Rigel Pharmaceuticals RIGL|anaptysbio.com (ANAB) - Short-Term Debt|ATXS - Company Short-Term Debt|ENGN (enGene Holdings Inc) - Company Short-Term Indebtedness|RAPT (RAPT Therapeutics) - Company Current Liabilities|Aerovate Therapeutics - Company Short-Term Loans and Borrowings|Company Short-Term Debt Aclaris Therapeutics|kyvernatx.com - Current Liabilities|Company Short-Term Debts TLSA|CABA (Cabaletta Bio Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debts VTYX (Ventyx Bio)|Company Short-Term Debts Theratechnologies, Inc THTX|AVTX - Company Short-Term Debt|Company Short-Term Loans and Borrowings AGEN (agenusbio.com)|Climb Bio (CLYM) - Company Short-Term Debt|Company Current Liabilities zurabio.com|ATYR (aTyr) - Company Short-Term Debts|Company Short-Term Debts Adagene Corp|Company Short-Term Debts IMA|Company Current Liabilities shattucklabs.com STTK|Company Short-Term Debts EQ (Equillium)|Connect Biopharma Holdings (CNTB) - Short-Term Debt|IMUX: Company Current Liabilities|ATRA - Company Short-Term Debts|IFRX (inflarx.de) - Company Current Liabilities|XFOR: Amount of Current Liabilities|ACET (Adicet Bio Inc.) - Company Short-Term Debts|Celularity Corp (CELU) - Short-Term Debt Volume|Company Short-Term Debts INMB|Company Current Liabilities Barinthus Biotherapeutics Corp BRNS|Company Short-Term Debts KZR (Kezar Life Sciences)|Company Short-Term Debts sabbiotherapeutics.com SABS|AKTX - Company Short-Term Debt|ENLV: Company Short-Term Debt|q32bio.com (QTTB) - Company Short-Term Debt|GOVX - Short-Term Debt Volume|EDSA (Edesa Biotech, Inc.) - Company Short-Term Debts|Short-Term Debt ibioinc.com IBIO|Company Short-Term Debt Carisma Therapeutics (CARM)|Company Short-Term Debt XTLB (XTL Biopharmaceuticals Ltd)|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|HCWB: Company Short-Term Indebtedness|APVO - Company Short-Term Debt|AIM (aimimmuno.com) - Company Short-Term Indebtedness|aditxt.com (ADTX) - Company Short-Term Debt|Current Liabilities GRI (GRI Bio Inc)|XRTX (XORTX) - Company Short-Term Debts|HIND: Company Short-Term Loans and Borrowings|Company Short-Term Debts REVB|Company Short-Term Debts indaptusrx.com (INDP)|Company Short-Term Debt Scinai Immunotherapeutics Ltd. SCNI|Company Short-Term Loans and Borrowings CALI|AFMD - Company Short-Term Debt|Allakos Inc. (ALLK) - Company Current Liabilities|HOOK: Company Short-Term Debts|IGM Biosciences (IGMS) - Company Short-Term Debts|Company Current Liabilities ITOS|OCEA: Company Short-Term Loans and Borrowings|Company Short-Term Debts TCBP|Short-Term Debt Volume Third Harmonic Bio Inc